Privium Fund Management B.V. Ionis Pharmaceuticals Inc Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Privium Fund Management B.V. holds 266,794 shares of IONS stock, worth $8.72 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
266,794
Previous 250,744
6.4%
Holding current value
$8.72 Million
Previous $10 Million
7.14%
% of portfolio
2.14%
Previous 2.51%
Shares
11 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$538 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$463 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$375 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$337 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$283 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...